Synthetic Biology
News articles and reporting on synthetic biology.
Twist Bioscience Q4 Revenues Jump 17 Percent on Strength of NGS, Synthetic Bio Offerings
The company reported a 20 percent increase in full-year revenues and predicted sustained revenue growth into fiscal year 2024.
Ginkgo Bioworks Q3 Revenues Drop as It Lowers Guidance on New Cell Engineering Programs in 2023
BTIG downgraded its rating for shares of Ginkgo from "Buy" to "Neutral." Though biosecurity revenues were down, cell engineering revenues grew 51 percent to $37.2 million.
Synthetic Yeast Chromosome Progress Presented in New Publications
In multiple papers, members of the Synthetic Yeast Project consortium known as Sc2.0 described progress in producing and studying synthetic yeast chromosomes and strains.
The program is being launched with "redeployment" of existing funding at the Sanger Institute as well as supplemental funding from the Wellcome charitable foundation.
Twist Bioscience, Bayer Ink $188M Antibody Discovery Deal
The deal is part of an "ongoing partnership" with Bayer and potentially the most lucrative antibody discovery agreement for Twist's biopharma division, so far.